×
This is a platform where everyone can voice their opinions and promote a free exchange of ideas, also if those ideas are controversial. We don't tolerate personal attacks, hate speech, racism, antisemitism or any threats of violence against an individual or a group. Also, no conspiracy theories. If you see any user comments that meet these criteria, please report them to us and we will look into it.
Report a comment
This is a platform where everyone can voice their opinions and promote a free exchange of ideas, also if those ideas are controversial. We don't tolerate personal attacks, hate speech, racism, antisemitism or any threats of violence against an individual or a group. Also, no conspiracy theories. If you see any user comments that meet these criteria, please report them to us and we will look into it.
×
Do you want to add this event to your calendar?
Add to your calendar
Do you want to add this event to your calendar?
×
Dear (name and title inserted automatically),
Contact legislators
Dear (name and title inserted automatically),
-
IntroducedMar 16, 2020
-
Passed Senate
-
Passed Assembly
-
Signed into Law
Requires public members of Drug Utilization Review Board to disclose financial interests and benefits received from and investment interests held in pharmaceutical distributors, pharmaceutical manufacturers, or pharmacy benefits managers.*
Last Action
Senate • Feb 09, 2021: Reported from Senate Committee with Amendments, 2nd Reading
Latest bill text
Official Summary/Bill Text
Comments on Bill
Tweets
Do you support this bill?
Sponsors:
Votes
Actions
- Feb 09, 2021 | Senate
- Reported from Senate Committee with Amendments, 2nd Reading
- Mar 16, 2020 | Senate
- Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee
Bill Texts
Documents